Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02135's Days Payable is ranked worse than 79.77% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 57.74
vs HKSE:02135: 23.79
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings Days Payable Chart
Raily Aesthetic Medicine International Holdings Annual Data
HKSE:02135 vs HCA, THC, DVA: Days Payable Comparison
For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raily Aesthetic Medicine International Holdings Days Payable vs Healthcare Providers & Services Industry
Raily Aesthetic Medicine International Holdings Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings (HKSE:02135) has a Days Payable of 23.05 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Raily Aesthetic Medicine International Holdings and its competitors. This is 34% below median its historical median of 34.81. Over the past decade, Raily Aesthetic Medicine International Holdings' Days Payable has ranged from 23.04 to 56.60. According to the industry distribution chart, Raily Aesthetic Medicine International Holdings ranks #485 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 79.8%.
Is Raily Aesthetic Medicine International Holdings' Days Payable too high?
Raily Aesthetic Medicine International Holdings' current Days Payable of 23.05 is 34% below median its 10-year median of 34.81. Over the past 10 years, this metric has ranged from a low of 23.04 to a high of 56.60. The Healthcare Providers & Services industry median Days Payable is 57.74. Raily Aesthetic Medicine International Holdings' value of 23.05 is 60.1% below this industry median. Based on the distribution chart, Raily Aesthetic Medicine International Holdings ranks #485 out of 608 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Raily Aesthetic Medicine International Holdings has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raily Aesthetic Medicine International Holdings' Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raily Aesthetic Medicine International Holdings ranks #485 out of 608 companies for Days Payable. This places Raily Aesthetic Medicine International Holdings in the lower half of its industry. The industry median Days Payable is 57.74. Raily Aesthetic Medicine International Holdings' value of 23.05 is 60.1% below this benchmark. Historically, Raily Aesthetic Medicine International Holdings' own Days Payable has ranged from 23.04 to 56.60 over the past decade. While the company's 10-year median is 34.81 vs. the industry median of 57.74, Raily Aesthetic Medicine International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 57.74, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raily Aesthetic Medicine International Holdings's current Days Payable of 23.05 is 60.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Raily Aesthetic Medicine International Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 57.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raily Aesthetic Medicine International Holdings's current Days Payable is 23.05, which is 34% below median its own 10-year median of 34.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raily Aesthetic Medicine International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings (HKSE:02135) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.12 — trading 15% below its estimated fair value. The current Days Payable is 23.05, which is 34% below median its 10-year median of 34.81 and 60.1% below the Healthcare Providers & Services industry median of 57.74. Raily Aesthetic Medicine International Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Raily Aesthetic Medicine International Holdings (HKSE:02135), the current Days Payable is 23.05 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raily Aesthetic Medicine International Holdings (HKSE:02135) Overvalued in 2026?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 15% below its estimated GF Value™ of HK$0.14.
GuruFocus considers Raily Aesthetic Medicine International Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02135:
Days Payable: 23.05 (34% below median its 10-year median of 34.81)
GF Value™: HK$0.14 vs. price of HK$0.12 (15% below fair value)
Industry Position: 60.1% below the Healthcare Providers & Services median (#485 of 608)
No single metric tells the full story. See the HKSE:02135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
47GF Score
Get the complete analysis for HKSE:02135
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02135 has been successfully added to your 
